NNZ 2591
NNZ 2591 is an orally active, blood-brain barrier permeable cyclic glycine-proline analogue. It has demonstrated neuroprotective effects in rodent models of ischemic brain injury and Parkinson's disease, supporting its research potential for conditions like Angelman syndrome.
Product Specifications
Molecular Weight
194.23
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog